Skip to main content
Premium Trial:

Request an Annual Quote

Jay Flatley, Jim Schlater, Charles Ted Bauer, William Sharp

Premium

Jay Flatley and Jim Schlater have joined the board of directors of GenVault, the San Diego-based biosample management company said last week. Flatley is president and CEO of Illumina. Prior to that, he was president and CEO of Molecular Dynamics. Schlater is founder and chairman of the board of directors of Cell Biosciences. He is also a co-founder of Applied Biosystems, and he was the first president and CEO of Molecular Dynamics.


Charles “Ted” Bauer of Houston, co-founder of the mutual fund company AIM Management Group, died Monday at 85. A graduate of Harvard College in 1942, and the holder of an MBA from New York University, Bauer helped fund the Bauer Laboratory and Bauer Center for Genomics Research at Harvard.


William Sharp joins Cellomics of Pittsburgh as vice president of business development. Previously, Sharp held the same position with Gentra Systems. Prior to that, he managed Invitrogen’s molecular biology business, and held posts at Heraeus Instruments and at Baxter Healthcare

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.